- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04735757
Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI
Effects of COVID-19-infection and Mechanical Ventilation on Movement and Tissue Characteristics of the Diaphragm, Visualized by Magnetic Resonance Imaging: a Proof-of-concept Study
COVID-19-infection has a large impact on the respiratory system and possibly on the diaphragm, the main respiratory muscle. In ICU-patients, diaphragm weakness is associated with prolonged ICU-stay, difficult weaning and increased mortality. Our research group recently found evidence for fibrosis and expression of genes involved in fibrosis as well as viral infiltration of the SARS-CoV-2 virus in diaphragm biopsies from COVID-19 ICU patients. This finding suggests a unique manifestation of diaphragm injury in COVID-19 patients after mechanical ventilation. However, it remains unclear what the exact nature and location of diaphragm injury is.
Additionally, it is largely unknown whether this injury affects the movement of the diaphragm, but this might have important clinical implications. Therefore, we aim at visualizing the tissue characteristics and movement of the diaphragm in COVID-19 patients who recently received long-term mechanical ventilation, other ICU patients and healthy controls, using magnetic resonance imaging (MRI). MRI of the diaphragm was already shown feasible in previous research from our group (article currently under review).
New insights in the characteristics of diaphragm weakness and injury in COVID-19 patients and control ICU-patients will contribute to strategies to prevent it and monitor the diaphragm of patients under mechanical ventilation, which can contribute to better patient outcomes.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Anticipado)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Países Bajos, 1081HV
- Reclutamiento
- Amsterdam UMC, location VUmc
-
Contacto:
- Myrte Wennen, MSc
- Número de teléfono: (020) 444 4444
- Correo electrónico: m.wennen@amsterdamumc.nl
-
Sub-Investigador:
- Myrte Wennen, MSc
-
Investigador principal:
- Leo Heunks, Prof. Dr.
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion criteria
In order to be eligible to participate in this study, a subject in the case group must meet all of the following criteria:
- Invasive mechanical ventilation > 72 hours during current hospital admission
- Admitted for COVID-19-infection (n = 10)
- Currently negative COVID-19 PCR test
- Discharged from the ICU ≤ 7 days ago
- Signed informed consent
- Age ≥ 18 years
In order to be eligible to participate in this study, a subject in the control group must meet all of the following criteria:
- Signed informed consent
- Age ≥ 18 years
- Similar age (max 5 years difference) and gender of one of the subjects in case group
Exclusion criteria
A potential subject for the case group who meets any of the following criteria will be excluded from participation in this study:
Known history of:
- Diaphragmatic injury or weakness prior to ICU stay
- COPD (GOLD IV)
- Neuromuscular disease (including pathology of the n. phrenicus)
- Connective tissue disease
- Chronic use of corticosteroids (>7.5 mg/day for at least 3 months before hospital admission)
- >10% weight loss within last 6 months prior to ICU admission
- Obesity (BMI > 30 kg/m2 at hospital admission)
- Known pregnancy
Contraindications for MRI
- Electrical/metallic implants
- Claustrophobia
- Unable to hold breath for 10 seconds
- Hierarchical relation with one of the collaborating investigators
- Incapacitation
Contraindications for the use of a Gadolinium based contrast agent for MRI
- Known eGFR < 30 ml/min/1.73m2
- Known history of allergic reactions to an MRI contrast medium
- Known history of allergic reactions requiring immediate treatment
- Known history of atopy
- Asthma These exclusion criteria are based on the guidelines for contrast agents from the European Society for Urogenital Radiology (http://www.esur.org/guidelines/).
Additional exclusion criteria for the case group, subset non-infected patients are:
• History of COVID-19-infection (confirmed with positive test)
Additional exclusion criteria for the control group are:
- History of mechanical ventilation > 24 hours
- History of COVID-19-infection (confirmed with positive test)
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
---|---|
Healthy volunteers
Healthy volunteers, matched by age and gender to patient groups.
|
Contrast-enhanced MRI
Measurement of the maximum inspiratory and expiratory pressure.
|
COVID-19 patients
Patients discharged from the ICU after invasive ventilation for COVID-19.
|
Contrast-enhanced MRI
Measurement of the maximum inspiratory and expiratory pressure.
|
ICU patients
Patients discharged from the ICU after invasive ventilation for ARDS.
|
Contrast-enhanced MRI
Measurement of the maximum inspiratory and expiratory pressure.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Tissue characteristics of the diaphragm
Periodo de tiempo: 1 hour
|
Extracted from contrast enhanced imaging
|
1 hour
|
Movement of the diaphragm
Periodo de tiempo: 1 hour
|
Description of the movement of the diaphragm in 4D fashion.
|
1 hour
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Quantitative dynamic contrast enhanced imaging of the diaphragm
Periodo de tiempo: 1 hour
|
Application of modelling to describe tissue characteristics of the diaphragm using contrast inflow.
|
1 hour
|
Correlation of movement and tissue characteristics of the diaphragm with measurements of maximum inspiratory and expiratory pressure
Periodo de tiempo: 1 hour
|
1 hour
|
|
Correlation of movement and tissue characteristics of the diaphragm with clinical parameters
Periodo de tiempo: 1 hour
|
Clinical parameters include ventilator settings, biomarkers for inflammation (CRP, white blood cell count) during ICU admission, daily dosage of drugs known with adverse effects on respiratory muscles, fluid balance, protein intake, primary reason for ICU admission and weaning duration.
|
1 hour
|
Otras medidas de resultado
Medida de resultado |
Periodo de tiempo |
---|---|
Correlation of diaphragm tissue characteristics with tissue characteristics of the abdominal muscles
Periodo de tiempo: 1 hour
|
1 hour
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- NL 72271.029.19
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre COVID-19
-
VA Office of Research and DevelopmentActivo, no reclutandoPacientes con EPOC y pacientes que se recuperan de COVID19Estados Unidos
-
HealthQuiltTerminadoFunción inmune | Paciente Positivo Covid19 | Covid19 contacto cercanoEstados Unidos
-
Bahçeşehir UniversityTerminadoLargo Covid19 | Disfunción autonómicaPavo
-
Ohio State UniversityReclutamientoSíndrome post-agudo de COVID19 | COVID largo | Condición posterior a COVID19Estados Unidos
-
Texas Woman's UniversityNational Institutes of Health (NIH)Aún no reclutando
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...Terminado
-
Fatima Memorial HospitalTerminado
-
Cairo UniversityKasr El Aini HospitalDesconocido
-
Assistance Publique - Hôpitaux de ParisDesconocido
-
Brugmann University HospitalReclutamiento
Ensayos clínicos sobre Contrast-enhanced MRI
-
Children's Hospital Medical Center, CincinnatiTerminadoEnfermedades inflamatorias del intestinoEstados Unidos
-
Kocaeli Derince Education and Research HospitalKocaeli UniversityDesconocidoRecuperación mejorada después de la cirugía | Cirugía a corazón abiertoPavo
-
University of AarhusTRYG FoundationDesconocidoDesorden de ansiedad socialDinamarca
-
Central Hospital, Nancy, FranceTerminado
-
Assistance Publique - Hôpitaux de ParisDesconocidoCirugía | Artroplastia total de rodilla | Colectomía | HisterectomíaFrancia
-
Rennes University HospitalBayerTerminadoEsclerosis múltiple (EM) | Enfermedad inflamatoriaFrancia
-
Chang Gung Memorial HospitalReclutamientoCancer de prostata | Imagen de resonancia magnética | Ensayo controlado aleatorizadoTaiwán
-
First Affiliated Hospital of Fujian Medical UniversityAún no reclutandoNeoplasias de la vejiga urinaria
-
Instituto Mexicano del Seguro SocialAún no reclutandoApendicitis | Niños, Solo | Recuperación mejorada después de la cirugía
-
Abbott Medical DevicesTerminado